Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
CNY 6.27
(0.48%)
CNY 6.27
(0.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 955.53 Million | 916.06 Million | 891.83 Million | 741.23 Million | 887.49 Million | 921.94 Million |
| Cost of Revenue | 262.77 Million | 255.9 Million | 245.85 Million | 220.12 Million | 232.4 Million | 236.73 Million |
| Gross Profit | 692.75 Million | 660.16 Million | 645.97 Million | 521.11 Million | 655.08 Million | 685.21 Million |
| Operating Expenses | 457.81 Million | 519.17 Million | 516.06 Million | 423.87 Million | 459.28 Million | 534.71 Million |
| Selling, General and Administrative Expenses | 316.55 Million | 414.27 Million | 415.75 Million | 309.42 Million | 331.82 Million | 396.53 Million |
| Research and Development Expenses | 44.47 Million | 47.89 Million | 39.44 Million | 31.22 Million | 33.45 Million | 36.44 Million |
| Other Expenses | 96.78 Million | 56.99 Million | 60.86 Million | 83.22 Million | 94.01 Million | -344.77 Thousand |
| Cost and Expenses | 720.59 Million | 775.07 Million | 761.92 Million | 643.99 Million | 691.69 Million | 771.44 Million |
| Operating Income | 234.93 Million | 188.79 Million | 150.27 Million | 117.87 Million | 184.95 Million | 159.46 Million |
| Interest Expense | 3.89 Million | 3.9 Million | 6.52 Million | 7.28 Million | 9.98 Million | 13.37 Million |
| Income Tax Expense | 21 Million | 14.23 Million | 15.05 Million | 11.48 Million | 26.4 Million | 18.35 Million |
| Earnings before Tax | 226.01 Million | 181.85 Million | 149.9 Million | 116.31 Million | 186.1 Million | 159.11 Million |
| Net Income | 205.01 Million | 167.61 Million | 134.84 Million | 106.14 Million | 159.69 Million | 140.76 Million |
| Earnings Per Share Basic | 0.41 | 0.33 | 0.27 | 0.21 | 0.32 | 0.28 |
| Earnings Per Share Diluted | 0.41 | 0.33 | 0.27 | 0.21 | 0.32 | 0.28 |
| Weighted Average Shares Outstanding | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.26 Million |
| Gross Margin | 0.72 | 0.72 | 0.72 | 0.70 | 0.74 | 0.74 |
| EBIT Margin | 0.29 | 0.30 | 0.28 | 0.27 | 0.33 | 0.24 |
| Profit Margin | 0.21 | 0.18 | 0.15 | 0.14 | 0.18 | 0.15 |
| EBITDA | 280.66 Million | 147.73 Million | 207.61 Million | 174.95 Million | 243.68 Million | 202.29 Million |
| Earnings Before Tax Margin | 0.25 | 0.21 | 0.17 | 0.16 | 0.21 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 213.53 Million | 222.03 Million | 248.82 Million | 936.62 Million | 266.14 Million | 212.46 Million |
| Cost of Revenue | 50.57 Million | 59.94 Million | 65.44 Million | 272.54 Million | 73.3 Million | 53.84 Million |
| Gross Profit | 162.96 Million | 162.08 Million | 183.38 Million | 664.07 Million | 192.83 Million | 158.62 Million |
| Operating Expenses | 122.57 Million | 123.2 Million | 122.64 Million | 494.23 Million | 93.62 Million | 145.19 Million |
| Selling, General and Administrative Expenses | 184.86 Million | 112.28 Million | 114.78 Million | - | 80.05 Million | 146.98 Million |
| Research and Development Expenses | 8.31 Million | 10.91 Million | 7.88 Million | - | 13.3 Million | 8.96 Million |
| Other Expenses | -70.6 Million | -14.43 Thousand | 24.3 Thousand | -82.21 Thousand | -265.69 Thousand | 95.2 Thousand |
| Cost and Expenses | 173.14 Million | 183.15 Million | 188.09 Million | 766.78 Million | 166.93 Million | 199.04 Million |
| Operating Income | 33.9 Million | 38.87 Million | 60.73 Million | 169.84 Million | 99.21 Million | 16.84 Million |
| Interest Expense | 530.4 Thousand | 590.9 Thousand | 901.79 Thousand | 3.67 Million | 756.58 Thousand | 1 Million |
| Income Tax Expense | 3.42 Million | 5.7 Million | 9.67 Million | 21 Million | 13.65 Million | -2.13 Million |
| Earnings before Tax | 33.68 Million | 41.39 Million | 63.93 Million | 168.26 Million | 92.27 Million | 16.94 Million |
| Net Income | 30.25 Million | 42.22 Million | 58.26 Million | 205.01 Million | 95.27 Million | 19.07 Million |
| Earnings Per Share Basic | 0.06 | 0.08 | 0.12 | - | 0.19 | 0.04 |
| Earnings Per Share Diluted | 0.06 | 0.08 | 0.12 | - | 0.19 | 0.04 |
| Weighted Average Shares Outstanding | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million | 503.2 Million |
| Gross Margin | 0.76 | 0.73 | 0.74 | 0.71 | 0.72 | 0.75 |
| EBIT Margin | 0.16 | 0.22 | 0.28 | - | 0.42 | 0.08 |
| Profit Margin | 0.14 | 0.19 | 0.23 | 0.22 | 0.36 | 0.09 |
| EBITDA | 34.21 Million | 48.56 Million | 68.46 Million | - | 112.84 Million | 17.27 Million |
| Earnings Before Tax Margin | 0.16 | 0.18 | 0.24 | 0.18 | 0.37 | 0.08 |
0853
CSW-B
3934
CTOWY
036830
AMAT